178 related articles for article (PubMed ID: 28553897)
21. Application of a parametric display of two-dimensional speckle-tracking longitudinal strain to improve the etiologic diagnosis of mild to moderate left ventricular hypertrophy.
Phelan D; Thavendiranathan P; Popovic Z; Collier P; Griffin B; Thomas JD; Marwick TH
J Am Soc Echocardiogr; 2014 Aug; 27(8):888-95. PubMed ID: 24874973
[TBL] [Abstract][Full Text] [Related]
22. Correlation between global longitudinal strain and QRS voltage on electrocardiogram in patients with left ventricular hypertrophy.
Beladan CC; Popescu BA; Calin A; Rosca M; Matei F; Gurzun MM; Popara AV; Curea F; Ginghina C
Echocardiography; 2014 Mar; 31(3):325-34. PubMed ID: 24015855
[TBL] [Abstract][Full Text] [Related]
23. Distinct role of electrocardiographic criteria in echocardiographic diagnosis of left ventricular hypertrophy according to age, in the general population: the Ikaria Study.
Tsiachris D; Chrysohoou C; Oikonomou E; Lazaros G; Dimitriadis K; Maragiannis D; Roussos D; Andreou I; Tsantilas A; Christoforatou E; Pitsavos C; Panagiotakos D; Stefanadis C
J Hypertens; 2011 Aug; 29(8):1624-32. PubMed ID: 21610511
[TBL] [Abstract][Full Text] [Related]
24. Diagnosis of cardiac amyloidosis based on the myocardial velocity profile in the hypertrophied left ventricular wall.
Oki T; Tanaka H; Yamada H; Tabata T; Oishi Y; Ishimoto T; Nagase N; Shinohara H; Sakabe K; Fukuda N
Am J Cardiol; 2004 Apr; 93(7):864-9. PubMed ID: 15050490
[TBL] [Abstract][Full Text] [Related]
25. The value of myocardial work in patients with left ventricular hypertrophy.
Fan J; Ma C; Wang H; Zhou B
Int J Cardiovasc Imaging; 2023 Jun; 39(6):1105-1113. PubMed ID: 36922462
[TBL] [Abstract][Full Text] [Related]
26. Regression of electrocardiographic left ventricular hypertrophy or strain is associated with lower incidence of cardiovascular morbidity and mortality in hypertensive patients independent of blood pressure reduction - A LIFE review.
Bang CN; Devereux RB; Okin PM
J Electrocardiol; 2014; 47(5):630-5. PubMed ID: 25052475
[TBL] [Abstract][Full Text] [Related]
27. Echo Parameters for Differential Diagnosis in Cardiac Amyloidosis: A Head-to-Head Comparison of Deformation and Nondeformation Parameters.
Pagourelias ED; Mirea O; Duchenne J; Van Cleemput J; Delforge M; Bogaert J; Kuznetsova T; Voigt JU
Circ Cardiovasc Imaging; 2017 Mar; 10(3):e005588. PubMed ID: 28298286
[TBL] [Abstract][Full Text] [Related]
28. Autonomic dysfunction in cardiac amyloidosis assessed by heart rate variability and heart rate turbulence.
Yamada S; Yoshihisa A; Hijioka N; Kamioka M; Kaneshiro T; Yokokawa T; Misaka T; Ishida T; Takeishi Y
Ann Noninvasive Electrocardiol; 2020 Jul; 25(4):e12749. PubMed ID: 32083399
[TBL] [Abstract][Full Text] [Related]
29. Comparison of usefulness of Sokolow and Cornell criteria for left ventricular hypertrophy in subjects aged <20 years versus >30 years.
Grossman A; Prokupetz A; Koren-Morag N; Grossman E; Shamiss A
Am J Cardiol; 2012 Aug; 110(3):440-4. PubMed ID: 22534054
[TBL] [Abstract][Full Text] [Related]
30. A simple echocardiographic score to rule out cardiac amyloidosis.
Aimo A; Chubuchny V; Vergaro G; Barison A; Nicol M; Cohen-Solal A; Castiglione V; Spini V; Giannoni A; Petersen C; Taddei C; Pasanisi E; Chacko L; Martone R; Knight D; Brown J; Martinez-Naharro A; Passino C; Fontana M; Emdin M
Eur J Clin Invest; 2021 May; 51(5):e13449. PubMed ID: 33185887
[TBL] [Abstract][Full Text] [Related]
31. Bone scintigraphy with (99m)technetium-hydroxymethylene diphosphonate allows early diagnosis of cardiac involvement in patients with transthyretin-derived systemic amyloidosis.
Glaudemans AW; van Rheenen RW; van den Berg MP; Noordzij W; Koole M; Blokzijl H; Dierckx RA; Slart RH; Hazenberg BP
Amyloid; 2014 Mar; 21(1):35-44. PubMed ID: 24455993
[TBL] [Abstract][Full Text] [Related]
32. Usefulness of Combining Electrocardiographic and Echocardiographic Findings and Brain Natriuretic Peptide in Early Detection of Cardiac Amyloidosis in Subjects With Transthyretin Gene Mutation.
Di Bella G; Minutoli F; Piaggi P; Casale M; Mazzeo A; Zito C; Oreto G; Baldari S; Vita G; Pingitore A; Khandheria BK; Carerj S
Am J Cardiol; 2015 Oct; 116(7):1122-7. PubMed ID: 26253999
[TBL] [Abstract][Full Text] [Related]
33. R Wave in aVL Lead is a Robust Index of Left Ventricular Hypertrophy: A Cardiac MRI Study.
Courand PY; Grandjean A; Charles P; Paget V; Khettab F; Bricca G; Boussel L; Lantelme P; Harbaoui B
Am J Hypertens; 2015 Aug; 28(8):1038-48. PubMed ID: 25588700
[TBL] [Abstract][Full Text] [Related]
34. Early diagnostic and prognostic value of myocardial strain derived from cardiovascular magnetic resonance in patients with cardiac amyloidosis.
Hou W; Wang Z; Huang J; Fan F; Yang F; Qiu L; Zhao K; Qiu J; Yang Y; Ma W; Gong Y; Hong T
Cardiovasc Diagn Ther; 2023 Dec; 13(6):979-993. PubMed ID: 38162105
[TBL] [Abstract][Full Text] [Related]
35. Differentiation of light-chain cardiac amyloidosis from hypertrophic cardiomyopathy using myocardial mechanical parameters by velocity vector imaging echocardiography.
Zhang L; Zhou X; Wang J; Mu Y; Liu B; Lv W; Wang Y; Liu H; Liu H; Zhi G
Int J Cardiovasc Imaging; 2017 Apr; 33(4):499-507. PubMed ID: 27878699
[TBL] [Abstract][Full Text] [Related]
36. Standard electrocardiographic criteria for left ventricular hypertrophy in Nigerian hypertensives.
Dada A; Adebiyi AA; Aje A; Oladapo OO; Falase AO
Ethn Dis; 2005; 15(4):578-84. PubMed ID: 16259479
[TBL] [Abstract][Full Text] [Related]
37. Regression of electrocardiographic left ventricular hypertrophy during antihypertensive treatment and the prediction of major cardiovascular events.
Okin PM; Devereux RB; Jern S; Kjeldsen SE; Julius S; Nieminen MS; Snapinn S; Harris KE; Aurup P; Edelman JM; Wedel H; Lindholm LH; Dahlöf B;
JAMA; 2004 Nov; 292(19):2343-9. PubMed ID: 15547161
[TBL] [Abstract][Full Text] [Related]
38. Echocardiographic markers of cardiac amyloidosis in patients with heart failure and left ventricular hypertrophy.
Melero Polo J; Roteta Unceta-Barrenechea A; Revilla Martí P; Pérez-Palacios R; Gracia Gutiérrez A; Bueno Juana E; Andrés Gracia A; Atienza Ayala S; Aibar Arregui MÁ
Cardiol J; 2023; 30(2):266-275. PubMed ID: 34355777
[TBL] [Abstract][Full Text] [Related]
39. Additional impact of electrocardiographic over echocardiographic diagnosis of left ventricular hypertrophy for predicting the risk of ischemic stroke.
Kohsaka S; Sciacca RR; Sugioka K; Sacco RL; Homma S; Di Tullio MR
Am Heart J; 2005 Jan; 149(1):181-6. PubMed ID: 15660051
[TBL] [Abstract][Full Text] [Related]
40. Discrimination of nonobstructive hypertrophic cardiomyopathy from hypertensive left ventricular hypertrophy on the basis of strain rate imaging by tissue Doppler ultrasonography.
Kato TS; Noda A; Izawa H; Yamada A; Obata K; Nagata K; Iwase M; Murohara T; Yokota M
Circulation; 2004 Dec; 110(25):3808-14. PubMed ID: 15583080
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
